Dianthus Therapeutics, Inc. /DE/ (DNTH)
Since Aug 09, 2018, Dianthus Therapeutics, Inc. /DE/ (DNTH) has reported earnings 30 times. On average the shares move ±4.87% post-earnings, with a positive reaction 60.0% of the time. Its largest post-earnings gain was +21.52% (Mar 09, 2026) and its largest decline was -7.05% (May 06, 2021). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings reactions
How DNTH moved on each past earnings report.
Earnings Impact
Total Earnings
30
Avg Abs. Movement
±4.87%
Positive %
60.0%
Negative %
40.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 05, 2026 | ☽ POST | +0.19% | open_in_new |
| Mar 09, 2026 | ☀ PRE | +21.52% | open_in_new |
| Nov 05, 2025 | ☽ POST | +8% | open_in_new |
| Aug 07, 2025 | ☽ POST | -2.04% | open_in_new |
Earnings Count
30
Total earnings in dataset
Avg Abs. Movement
±4.87%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260713 | open_in_new SEC.gov |
| 144 | 20260709 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 144 | 20260617 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 144 | 20260601 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
Frequently asked about DNTH earnings
When does Dianthus Therapeutics, Inc. /DE/ report earnings next? expand_more
Dianthus Therapeutics, Inc. /DE/ (DNTH)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNTH stock move after earnings? expand_more
Over 30 reports, DNTH has moved an average of ±4.87% the session after earnings, closing higher 60.0% of the time.
What was DNTH's biggest post-earnings move? expand_more
DNTH's largest post-earnings gain on record was +21.52% on Mar 09, 2026, and its largest decline was -7.05% on May 06, 2021.
Where can I find Dianthus Therapeutics, Inc. /DE/'s SEC filings? expand_more
All of Dianthus Therapeutics, Inc. /DE/'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07